TMPRSS11D and glioblastoma: These data indicated that the combination of Palbociclib and C646 might be an effective therapeutic strategy for glioblastoma, further implying that P300 HAT inactivation might be considered to be employed to sensitize GBM cell to cell cycle blockade.